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Abstract
Heregulin ß-1 (HRG) is an extracellular ligand that activates mitogen-activated protein kinase (MAPK) and phosphatidy-
linositol-3-OH kinase (PI3K)/Akt signaling pathways through ErbB receptors. MAPK and Akt have been shown to
phosphorylate the estrogen receptor (ER) at Ser-118 and Ser-167, respectively, thereby mimicking the effects of estrogenic
activity such as estrogen responsive element (ERE)-dependent transcription. In the current study, integrative analysis was
performed using two tiling array platforms, comprising histone H3 lysine 9 (H3K9) acetylation and RNA mapping, together
with array comparative genomic hybridization (CGH) analysis in an effort to identify HRG-regulated genes in ER-positive
MCF-7 breast cancer cells. Through application of various threshold settings, 333 (326 up-regulated and 7 down-regulated)
HRG-regulated genes were detected. Prediction of upstream transcription factors (TFs) and pathway analysis indicated that
21% of HRG-induced gene regulation may be controlled by the MAPK cascade, while only 0.6% of the gene expression is
controlled by ERE. A comparison with previously reported estrogen (E2)-regulated gene expression data revealed that only
12 common genes were identified between the 333 HRG-regulated (3.6%) and 239 E2-regulated (5.0%) gene groups.
However, with respect to enriched upstream TFs, 4 common TFs were identified in the 14 HRG-regulated (28.6%) and 13 E2-
regulated (30.8%) gene groups. These results indicated that while E2 and HRG may induce common TFs, the regulatory
mechanisms that govern HRG- and E2-induced gene expression differ.
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Introduction
Heregulin ß-1 (HRG) is an extracellular ligand that binds to and
activates ErbB3 and ErbB4 receptors in a process associated with
the control of cell proliferation and differentiation [1–3].
Our previous study using MCF-7 breast cancer cells showed
that HRG rapidly up-regulated hundreds of transcripts in a ligand
dose-dependent manner, as determined by employing expression
arrays using the Affymetrix U133A 2.0 chip that mounts protein-
coding and non-protein coding regions of ca. 18,400 transcripts
[4]. HRG-stimulated ErbB receptor is known to activate mitogen-
activated protein kinase (MAPK) and phosphatidylinositol-3-OH
kinase (PI3K)/Akt signaling pathways [5]. Consequently, the
transcriptional regulation induced by HRG was thought to be
controlled by activation of the aforementioned signaling pathways
and associated transcription factors (TFs). On the other hand,
MAPK and Akt are also known to phosphorylate the estrogen
receptor (ER) at Ser-118 and Ser-167, respectively, thereby
mimicking the effects of estrogenic activity in ER-positive cells in
the absence of estrogen (E2) [6–8]. Activated ER is believed to
bind directly to the estrogen responsive element (ERE) DNA
sequence and subsequently induce ERE-dependent transcription
[9]. Given that MCF-7 is an ER-positive breast cancer cell line,
HRG-induced transcription may involve both ERE- and non-
ERE-dependent regulation.
In our earlier study using the Affymetrix U133A 2.0 chip,
however, we found that only 6 transcripts among the 241 HRG-
regulated transcripts (2.49%) were derived from genes that
possessed the ERE sequence within a 2 kb upstream region of
the transcription start site (TSS) [4]. Notwithstanding the fact that
HRG-stimulated MCF-7 cells showed ERE-mediated suppression
of histone acetylation and gene expression [10], the population of
ERE-regulated transcripts in our analysis seemed to be relatively
low. This suggested the possibility that use of the expression array
platform may have failed to identify the complete range of
transcripts associated with HRG-induced gene regulation. In the
current study, integrative analysis of HRG-induced gene expres-
sion in MCF-7 cells was performed using two tiling array platforms
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and RNA mapping. Array comparative genomic hybridization
(CGH) analysis was also employed in an effort to identify gene
expression unrelated to HRG treatment.
Integrated analysis of the expression data using various array
platforms facilitated the identification of transcripts that were
regulated in cells following HRG treatment. The data showed that
326 genes were up-regulated and 7 genes were down-regulated.
Prediction of upstream TFs and mapping onto the biological
pathways indicated that 21% (69 out of 333) of the genes
associated with HRG-induced gene regulation may be controlled
by TFs known to be activated by the MAPK cascade, while only
0.6% (2 out of 333) of the gene expression is controlled by ERE.
Comparison with previously reported data pertaining to E2-
regulated genes [11,12] revealed that only 12 common genes were
identified between the 333 HRG-regulated (3.6%) and 239 E2-
regulated (5.0%) gene groups. However, with respect to upstream
TFs that are more likely to be enriched, 4 common TFs were
identified in the 14 HRG-induced (28.6%) and 13 E2-induced
(30.8%) gene groups. These results indicated that while E2 and
HRG may induce common TFs, the regulatory mechanisms that
govern HRG- and E2-induced gene expression differ.
Results
Stimulation by HRG induces phosphorylation of ER at
Ser-118 and Ser-167 in MCF-7 cells
Modes of ER activation have been categorized largely on the
basis of steroid (E2)-dependent and steroid-independent mecha-
nisms. E2 binds directly to ER thereby facilitating ER dimeriza-
tion and subsequent high affinity binding to ERE (referred to as
steroid-dependent ER activation) [13]. Growth hormones such as
epidermal growth factor (EGF) and insulin-like growth factor
(IGF)-I have been shown to activate ER by phosphorylating ER at
Ser-118 through activation of MAPK [6]. On the other hand, Akt
and pp90
rsk1 activated by EGF have been shown to phosphorylate
ER at Ser-167 [7,8,14]. These steroid-independent activations of
ER are also capable of leading to ER- and ERE-mediated
transcription events. HRG is a growth hormone ligand that
strongly activates MAPK and PI3K/Akt through ErbB receptor
activation [1–4]. We first assessed an assay to confirm that HRG
induces ER phosphorylation at Ser-118 and Ser-167 in MCF-7
cells in our culture condition. The results clearly indicated
that HRG treatment immediately induced phosphorylation at
both serine residues (Figure 1). These results are consistent with
an earlier report showing HRG-dependent ER activation [15].
On the other hand, E2 induced weak phosphorylation at Ser-118
and no phosphorylation at Ser-167. We assumed that ER is
strongly activated by HRG under the assay conditions used in this
study.
Comparison of histone acetylation and RNA mapping
data with expression array data
HRG-induced gene expression data obtained from various
array platforms including the tiling array data was then
investigated. These data were submitted to Gene Expression
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) and can be ac-
cessed through GEO series accession numbers GSE8579 (tiling
arrays, histone H3K9 acetylation and RNA mapping) and
GSE8471 (expression arrays) and GSE8508 (array CGH)
Although chromatin modification by H3K9 acetylation has
been linked to the regulation of gene expression, the precise
correlation between the extent of histone acetylation and gene
expression remains unclear [16,17]. On the other hand, although
use of RNA mapping on whole-genome tiling arrays seems to
represent an unbiased approach [18], this method often yields
many false-positive and false-negative values. Therefore, the
current study employed an analysis that began with an evaluation
of acetylation and RNA map data sets.
In an effort to determine whether the tiling array data
accurately reflects the gene expression profile, HRG-mediated
up- and down-regulated genes were initially identified from
the histone acetylation and RNA map data (see Materials
and Methods section). To this end, 27,354 RefSeq transcripts
were selected that correspond to 17,843 Entrez Gene IDs
(hereafter, the 17,843 genes are referred to as the baseline set).
To assess the validity of the gene selection, the derived gene list
was compared with genes that were identified in expression arrays
as a reference indicator (see Materials and Methods for the
selection).
HRG-induced up- and down-regulation of genes was assessed
by identifying signal differences between HRG-treated and
untreated cells. The difference in acetylation signal dA and that
of the RNA map dR were calculated as follows: dA=Ahrg–Acontrol and
dR=Rhrg–Rcontrol, where Ahrg and Rhrg represent acetylation and
RNA map signals in HRG-treated cells, respectively, and Acontrol
and Rcontrol represent acetylation and RNA map signals in
untreated cells, respectively. If dA or dR was greater than 0, the
gene was regarded as being up-regulated. Figure 2 shows the
distribution of these values. The average value of dA (2.7, black
dotted line in Figure 2A) and dR (0.67, black dotted line in
Figure 2B) and the distribution peak were greater than 0, which
implies that HRG treatment induced up-regulation of histone
acetylation and RNA mapping. If gene expression changes (up- or
down-regulation) can be identified by examining acetylation (or
RNA map) signals, it is anticipated that this would be reflected in
the form of a distinct spread of dA (or dR) values relating to up- and
down-regulated genes. However, when independently comparing
the signal distribution pertaining to the acetylation (or RNA map)
data with the expression array results, no clear difference was
observed (red and green dashed lines were not distinct in Figure 2).
Thus, our analysis revealed that independent tiling array analysis
may have failed to identify the complete range of transcripts
associated with HRG-induced gene regulation.
In an effort to confirm this possibility, the overlapping rate of
genes selected from each tiling array was then compared with the
gene list derived from the expression array analysis. For the
selection of up-regulated genes from the histone acetylation data,
the criterion Ahrg2Acontrol$a was adopted. If a gene exceeded
threshold a, such a gene was regarded as being up-regulated. In
the same way, Rhrg2Rcontrol$b was used for the RNA map data.
Table 1 shows the relative ratio of up-regulated genes that were
found in each tiling array data and expression array-based gene list
under various thresholds of a and b. In general, increased
thresholds resulted in higher overlapping rates. However, even
with such a tight threshold setting, more than 50% of the genes
selected from the histone acetylation data were not covered in
the gene list obtained from the expression array data. The RNA
map data show a higher overlapping rate when the number of
genes obtained is quite small (b=4 gives only 29 overlapping
genes).
The threshold setting used to identify regulated genes from the
above two integrated tiling array data sets was then examined. In
this analysis, genes that only satisfied both Ahrg2Acontrol$a and
Rhrg2Rcontrol$b were compared with results of the expression
arrays. Figure 3 represents the percentage (A and B) and number
(C and D) of genes that were identified as being up-regulated from
the combined tiling array data and which were also found in the
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Genome-Wide Analysis of MCF-7expression array results under various threshold (a and b) settings.
As shown, increasing a (Figure 3A) and b (Figure 3B) yielded
higher overlapping rates from the two tiling array data and
expression array data sets. In contrast, increasing the threshold
resulted in the identification of fewer genes (Figure 3C and D). b
has a higher contribution to the precision rate and number of
genes identified compared with a. For specific combinations of a
and b (e.g. a=4 and b=4), 100% of the tiling array inferred that
up-regulated genes were found in the expression array results.
However, only 19 genes were identified in that setting. There is a
trade-off between precision rate and the number of identified
genes. Two parameters, rmin (minimum precision rate) and N
(number of extracted genes), need to be determined in order to
arrive at a reasonable threshold setting. Here, rmin and N were set
to 70 and 300, respectively. Under these conditions, the largest b
value was searched for and a was then determined since a larger
threshold results in a higher precision rate. Finally, a=4 and b=2
was obtained and these values were used as thresholds. As a result,
326 and 7 genes were identified as being up- and down-regulated,
respectively, following HRG treatment of cells (Table S1). With
this setting, the up- and down-regulation of 72.4% of these
transcripts (241 out of 333 genes) was confirmed with the
expression array data.
Identification of HRG-induced genes from acetylation
and RNA mapping data and confirmation using
expression array data
As described above, 326 genes up-regulated following HRG
treatment were chosen from the tiling array-based H3K9
acetylation and RNA mapping data sets. Three-hundred and
eighteen of the 326 genes (97.5%) have corresponding probe sets
on the expression array. The remaining 8 transcripts identified by
the tiling array were manually inspected using a web-based
genome browser [19]. As a result, only one gene, LOC400214, was
identified as a novel candidate (Figure S1), which was not mounted
on an expression array chip. Although this gene was derived from
RefSeq model mRNA (XM_375081), an elevated level of
acetylation in the promoter region (2nd and 3rd lanes in Figure
S1) and increased RNA map signals in exons (4th and 5th lanes in
Figure S1) indicate that this transcript may also be induced
following HRG treatment of MCF-7 cells.
Of the 7 down-regulated genes inferred by the tiling array data,
genes known to be down-regulated following HRG treatment,
including the ER gene (ESR1), were not detected in our dataset.
This was due to the fact that although the ESR1 gene was down-
regulated as determined by the histone acetylation analysis (56.3
for untreated cells vs. 44.5 for HRG-treated cells), it was slightly
Figure 1. Estrogen receptor phosphorylation induced by HRG and E2. Phosphorylation levels of estrogen receptor alpha at Ser-118 and Ser-
167 treated with HRG (10 nM) or E2 (10 nM) were measured at the designated time period. Three-independent western blots were performed for
each ligand. Representative figures are shown on the left. Levels of phosphorylation were quantified using a densitometer and are shown graphically
on the right.
doi:10.1371/journal.pone.0001803.g001
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untreated cells vs. 8.93 for HRG-treated cells). As for the down-
regulated genes in our dataset, one gene had no associated probe
set in the Affymetrix U133 Plus 2.0 chip and 3 genes were
removed due to weak expression intensities. Finally, although the
down-regulation of all 3 genes (ATAD4, C6orf139 and CRADD) was
confirmed using results of the expression arrays, however, these
genes do not possess regulatory binding sites for ER or ERE at the
promoter region.
Relationship between transcriptional activity and copy
number
Since MCF-7 is a cancer cell line, there was a concern that high
genome copy numbers in the cells may result in strong gene
expression in the absence of HRG that may potentially obscure
any HRG-related effects. The relationship between gene expres-
sion and genome copy number was therefore investigated utilizing
the array CGH data. Actively transcribed regions were screened
from the whole genome in an unbiased fashion by searching for
chromosomal regions with significant acetylation and RNA
mapping signals in untreated cells. As a result, 2,163 regions were
identified to be actively transcribed in the absence of exogenous
stimuli. The average relative copy number in these regions and for
the whole genome was 1.12 and 1.03, respectively.
Copy numbers for the 326 HRG-induced up-regulated genes
were then examined in an effort to investigate genomic
amplifications. The location of genes was obtained from the
Entrez Gene database and compared to that of SNP markers
where the copy number was calculated. Where a gene locus
contained multiple SNP markers, an average copy number was
assigned. If no marker was present, copy numbers from the nearest
59 and 39 end of a gene were used to calculate the corresponding
gene. As a result, an average relative copy number of 1.02 was
obtained for the 326 HRG-induced up-regulated genes (1.03 for
Figure 2. Distribution of signal differences dA and dR between HRG-treated and untreated cells. Upper and lower panel shows the
distribution of acetylation and RNA map signal differences, dA (=Ahrg–Acontrol) and dR (=Rhrg–Rcontrol) (A and B), respectively. Larger dA (or dR) values
represent a higher level of acetylation (or RNA map) in HRG-treated cells compared with untreated cells. Red and green dashed lines show the
distribution of these values in the expression array and represent up- and down-regulated genes, respectively. Colored dotted lines depicted along
the vertical axis represent average values of each distribution.
doi:10.1371/journal.pone.0001803.g002
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NME1, PTRH2 and TRIB1) had copy numbers greater than 1.5
(Figure S2). However, this low frequency of high copy number in
the selected genes can be considered to have negligible
contribution to the overall gene expression. Therefore, it was
concluded that HRG-induced up-regulation of genes detected by
tiling arrays essentially reflects that activity associated with HRG
treatment, rather than chromosomal amplification.
Functional characteristics of HRG-regulated genes
In an effort to investigate the regulatory mechanism relating to
the 326 up-regulated and 7 down-regulated genes associated with
HRG treatment, the biological function of these genes was
examined using two public data sources comprising the transcrip-
tion factor binding site (TFBS) information in the UCSC genome
browser database [20] and the KEGG pathway database [21].
TFBSs for the 333 genes were predicted using the UCSC
genome browser database in an effort to provide information on
potential upstream regulatory elements that link biological
pathways and HRG-regulated gene expression. Genomic coordi-
nate of genes were obtained by mapping the mRNA sequences
derived from the UCSC genome browser database. TFBSs located
within a 2 kb upstream region from the TSS were then used to
find candidate TFs. As a result, 754 potential transcriptional
regulatory relationships were found for 62% (208 out of 333) of the
HRG-regulated genes. The 208 genes possess predicted TFBSs for
117 TFs (Table S2). Rigorous statistical testing did not result in
significant enrichment of the 117 TFs. However, TFs such as
CREB1, ATF2 and EGR1, which are known to be activated
immediately following growth hormone stimulation, showed
relatively small p-values (p,0.05, before multiple test correction).
The predicted TFs were then assigned to signaling pathways
using a public database to determine the contribution of specific
biological pathways to gene transcription. As a result, the MAPK
pathway was found to be the most significant pathway associated
with 13 TFs (Figure 4; enrichment of this pathway was supported
by Fisher’s exact test, p,10
24). Sixty-nine HRG-regulated genes,
which account for 21% of the 333 genes, possess binding sites for
13 MAPK-regulated TFs. Of these, 5 TFs involved in the MAPK
pathway possessed small p-values (Table S3).
Relationship with ER and signaling pathway
As shown in Figure 1, HRG treatment facilitated phosphory-
lation of ER at Ser-118 and Ser-167 and therefore seems to
activate ER under the assay conditions used. Whereas E2 did not
show Ser-167 phosphorylation of ER in our assay condition, both
E2 and HRG are capable of phosphoylating ER at Ser-118 that is
required for ER-dependent transcription [22,23]. Therefore, if a
portion of HRG-regulated transcription was mediated by ER in
this study, some genes that are also regulated by E2 should be
overlapped since E2 and HRG may utilize common ER or ERE-
dependent transcription mechanism through Ser-118-mediated
ER activation.
A comparison of our gene list with two published gene lists
obtained by expression array experiments using E2-stimulated
MCF-7 cells [11,12] was employed to determine whether the 333
HRG-regulated and 239 E2-regulated gene groups contained
common genes. As a result, it was found that only 12 genes were
common to both gene groups, representing 5.0 and 3.6% of the
E2- and HRG-regulated gene groups, respectively. (Table S1).
In an effort to identify upstream regulators common to both
HRG- and E2-mediated gene expression, candidate TFs predicted
from E2-regulated gene sets were analyzed. TFBS prediction
yielded 731 potential transcriptional regulatory relationships that
were comprised of 112 TFs and 170 genes for E2. Unexpectedly,
of the 239 E2-stimulated genes, only 5 genes (BHLHB2, BRCA1,
DYRK2, FOS and GREB1) possessed binding sites for ER or ERE
at the promoter region (within 2 kb upstream from the TSS). This
result indicated the potential involvement of transcriptional
regulators other than ERE, such as AP-1 and Sp1, in E2-regulated
gene expression [24,25]. A comparison of the 117 HRG TFs and
112 E2 TFs identified a total of 111 TFs common to both TF
groups. Furthermore, 12 TFs (10.7% of the 112 TFs) predicted
from the E2-regulated genes are involved in the MAPK signaling
pathway (Figure S3) and all of which were common to the 13 TFs
associated with the HRG-regulated genes. Even when TFs
enriched in HRG- and E2-regulated genes were investigated
(p,0.05, before multiple test correction), 4 TFs were still identified
as being common to the 14 and 13 HRG- and E2-related TF
groups, respectively. For example, ARNT was commonly predicted
from 9 HRG-regulated and 7 E2-regulated genes. Interestingly,
however, the expression level of KLF6, one of the target genes of
ARNT, increased with HRG treatment and decreased with E2
treatment. This result indicates that TFs activated following E2
and HRG stimulation may yield opposite effects in terms of gene
regulation. Additionally, our analysis revealed that HRG- and E2-
regulated gene sets contain few common members. These overall
analytical results suggest that E2 and HRG depend considerably
on the MAPK pathway for transcriptional control, where each TF
may be differentially regulated by other factors, thereby resulting
in the induction of different sets of genes. However, as expected,
the presence of enriched TFs in the MAPK signaling pathway, 5
(out of 14) TFs for HRG and 1 (out of 13) TFs for E2, suggests that
HRG is more dependent on this pathway.
Discussion
In this study, integrative analysis of HRG-regulated gene
expression in MCF-7 cells was performed using two types of tiling
Table 1. Comparison of up-regulated genes obtained from
each tiling array data with the expression array results.
A Common genes as determined from the acetylation data at various
thresholds (a)
a % common genes No. common genes
0 28.64 3028
2 34.96 2380
4 39.28 1869
6 42.47 1471
8 44.10 1155
10 45.09 881
B Common genes as determined from the RNA map data at various
thresholds (b)
b % common genes No. common genes
0 30.39 3905
1 45.44 2206
2 61.10 476
3 76.67 92
4 90.63 29
doi:10.1371/journal.pone.0001803.t001
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mapping, and compared the results with those based on expression
array and array CGH. Following the determination of various
threshold settings, 333 transcripts that were regulated by HRG
were finally identified. The up- and down-regulation of 72.4% of
these transcripts (241 of the 333 genes) was confirmed using
expression arrays.
EGF, a growth hormone ligand for EGFR/ErbB1 receptor, is
known to induce coupling of phosphorylation and acetylation of
histone H3 that results in enhanced gene expression [26]. Our
current analysis with HRG also indicated that histone acetylation
and gene up-regulation may be closely related.
Our current results indicated that the majority of HRG-
regulated genes were up-regulated (326 of the 333 genes).
However, since MCF-7 is a cancer cell line, there was a concern
that high genome copy numbers in the cells may result in strong
gene expression in the absence of HRG that may potentially
obscure any HGR-related effects. Genes such as NCOA3, PPM1D,
PSMD6 and BCAS2 were detected with high expression and copy
numbers in MCF-7 cells (Figures 5 and 6), and these genes have
been associated with breast cancer progression [27–30]. However,
our analysis revealed that the overall correlation between average
copy number and the extent of gene expression was surprisingly
weak.
The frequency of occurrence of ER or ERE-mediated
transcription was investigated using integrated gene expression
analysis. Surprisingly, whereas HRG treatment resulted in the
phosphorylation of ER at Ser-118, which is thought to lead to ER
activation, ER- or ERE-dependent transcription induced by HRG
seemed to be quite minor (0.6%). To account for this observation
we initially speculated that it was due to the short exposure time (2
hrs) of the cells to HRG, or perhaps to a lack of depletion of E2-
Figure 3. Comparison of tiling array-inferred up-regulated genes and expression array results at various thresholds. The proportion
of genes that were identified as up-regulated and also found in the expression array-based gene list at various thresholds of a and b ((A) and (B)). (C)
and (D) represent the number of identified genes.
doi:10.1371/journal.pone.0001803.g003
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down-regulate ER levels [15,31]. In an effort to address this issue,
it was confirmed by western blot analysis that HRG could
phosphorylate ER under the culture conditions used (Figure 1). As
for the exposure time, given that 4–48 hrs of E2-stimulated gene
regulation failed to show ERE at its upstream region, a complex
regulatory mechanism for gene expression rather than the
exposure time of cells to stimuli seems to be a major factor. In
fact, recent analysis of ER-alpha binding on the whole genome
revealed that 95% of ERE binding sites of targeted genes are
located at intronic or distal locations (.5 kb from 59 and 39 ends
of the transcript) [32], its regulation seems to be far more complex
than that associated with MAPK-regulated transcription. Addi-
tionally, our current analytical results suggested the presence of
distinct regulatory roles for TFs that yield opposite effects in terms
of HRG- and E2-induced gene regulation. ER expression and
activation is widely regulated by various signaling pathways and
kinases [33–35]. The current study has provided some insight into
the similarities and differences between complex regulatory
mechanisms in growth hormone- and E2-induced gene expression
in ER-positive breast cancer cells.
Materials and Methods
Cell culture
The MCF-7 human breast cancer cell line was obtained from
the American Type Culture Collection and maintained in DMEM
medium supplemented with 10% fetal bovine serum. Prior to
growth hormone treatment, cells were serum-starved for 16–
24 hours. For the expression analysis, 10 nM HRG-b 176–246
(R&D Systems) was added to the cells and incubated for 2 hrs.
Cells untreated with growth hormone were used as the control.
ER phosphorylation
For the ER phosphorylation assay, cells were incubated with
HRG (10 nM) or E2 (10 nM) for up to 90 min. Cells were then
rinsed with ice-cold PBS and lysed using the Bio-Plex Cell Lysis
Kit (Bio-Rad Laboratories). The cell lysate was cleared by
centrifugation, and the protein concentration of the supernatant
was determined using DC protein assay reagent (Bio-Rad
Laboratories). Equal amounts of protein were subjected to
Western blot analysis. Electrophoretically resolved proteins were
blotted and subsequently probed with anti-phospho-Ser-118
Figure 4. HRG-regulated TFs involved in the KEGG MAPK signaling pathway. Thirteen TFs included in the 117 HRG-regulated TF list
involved in the MAPK signaling pathway and are highlighted in red. Note that since Elk-1 appears twice in the figure (downstream of classical MAP
kinase pathway and JNK and p38 MAP kinase pathway), 14 boxes are highlighted.
doi:10.1371/journal.pone.0001803.g004
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ing Technology, Inc.) and anti-ER (Upstate Biotechnology, Inc.)
antibodies. Phosphorylated proteins were quantified using a
densitometer.
Expression array
Expression array experiments were performed using the
Affymetrix Human Genome U133 Plus 2.0 Chip (Affymetrix,
Santa Clara, CA, USA) that encodes 54,000 probe sets (with
47,000 transcripts and variants that includes 38,500 well-
characterized genes) for integrative expression analyses of RNA
mapping and histone acetylation, and for verification of the
expression of novel transcripts. Hybridization and washing were
performed according to the manufacturer’s protocol. Signals were
processed according to the GeneChip expression analysis
algorithm (GCOS ver. 1.2) (Affymetrix). Probe sets with a low
signal (100) were discarded in subsequent analyses. Relative
changes in expression levels of HRG-treated cells against
untreated cells were transformed using a log2 function. A gene
was regarded as being up-regulated if this value was greater than
0.
ChIP on chip experiment to measure the level of
acetylation at lysine 9 of histone H3
The level of enrichment for acetylation at lysine 9 of histone H3
(H3K9Ac) in the human genome was determined using the
Affymetrix whole-genome tiling array (Affymetrix Human tiling
array 1.0), which tiles the non-repetitive portion of the human
genome at 35-bp intervals with more than 41 million pairs of 25-
mer probe sequences. The experimental protocol employed was
that previously described [36]. MCF-7 cells were fixed with 1%
formaldehyde and sonicated using a Branson 450 Sonifier. The
sonicated lysates were pre-cleared using protein G sepharose.
Following removal of control aliquots, the pre-cleared lysates were
treated with anti-acetylated K9 histone H3 antibody (Upstate
Biotechnology, Inc.). The immune complexes were precipitated
with protein G dynabeads (Dynal, Invitrogen), washed and eluted
from the beads. The eluted immune complexes were reverse cross-
linked and treated with RNase and Proteinase K. The precipitated
DNA was extracted using a phenol/chloroform method and
ethanol precipitation. Both the precipitated (treated) and control
DNA (whole-cell extract) was amplified using the ligation mediated
(LM)-PCR method. The amplified DNA was purified, fragmented
with DNase I and end-labeled with biotin-ddATP. The end-
labeled DNA was hybridized to the tiling array for 18 hrs at 45uC.
Following hybridization, arrays were washed and scanned using
the Affymetrix GeneChip System.
The hybridization intensities (background-subtracted intensity;
PM–MM, where PM and MM represent intensities detected by a
25-mer comprising perfectly matching and one-base-mismatching
genome sequences, respectively) of the probes were measured in
triplicate for each of the treated and control samples. A shift in
intensity of the treated relative to control data in a 400-bp window
centered at each probe was evaluated using a Wilcoxon Rank
Sum test, which assigned a p-value to the probe position [37]. The
TAS Affymetrix software (http://www.affymetrix.com/support/
developer/downloads/TilingArrayTools) was used for p-value
calculations.
RNA mapping and computation of signal intensity
RNA mapping experiments using the Affymetrix tiling array
were performed as previously described [38]. Fifteen micrograms
of total RNA was used as a template for first-strand synthesis.
Double-stranded cDNAs were synthesized using reverse tran-
scribed cDNAs as templates. Double-stranded cDNAs were
purified, fragmented, end-labeled and hybridized to the tiling
arrays in triplicate. Hybridized arrays were washed and scanned
using the Affymetrix GeneChip System. The signal intensity at
each probe position was computed using the TAS Affymetrix
software. A Wilcoxon signed-rank test was applied to hybridization
intensities measured at probes located within 650 bp of every
probe location, and the pseudomedian generated by the Wilcoxon
test was assigned as an estimate of the signal intensity to the probe
position [39]. The signal intensity is given on a log2 scale.
Level of acetylation at lysine 9 of histone H3 in the
promoter region of protein-coding genes
Using the 59 ends of mRNA sequences (RefSeq database: ftp://
ftp.ncbi.nih.gov/refseq) aligned to the genome as the TSS, we
attempted to measure the magnitude of H3K9Ac enrichment in
the promoter region (61.5 kb of TSS) of the genes. We considered
the highest, average and median of 210 log (p-value) detected by
the probes located in the promoter region.
Estimation of the expression level of genes from the RNA
mapping data
The signal intensities given by the RNA mapping were used to
estimate the expression level of genes in the human genome. The
average signal intensity of the probes located in exons of each gene
was used as an indicator of the expression level. Only genes that
were mapped by 50 (tentative) or more probes were used in the
analysis.
Array CGH analysis
Genome-wide DNA screening on an Affymetrix GeneChip
Mapping 250K Nsp EA array was performed using the GeneChip
Instrument system according to the standard protocols of the
manufacturer (Affymetrix). Briefly, genomic DNA was digested
with restriction endonuclease, ligated to an adaptor, and subjected
to PCR amplification with adaptor-specific primers. The PCR
products were digested with DNase I and labeled with a
biotinylated nucleotide analogue using terminal deoxynucleotidyl
transferase. The labeled DNA fragments were hybridized to the
microarray, the hybridized DNA probes were captured by
streptavidin-phycoerythrin conjugates, and the array was scanned.
The signal intensity ratio was calculated as previously described
with some modifications [40]. For this analysis, the publicly
available data-Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) accession number GSE5013 was employed as the
reference data. A moving average of the signal intensity ratio
across 5 adjacent markers was calculated and mapped onto the
human genome according to the physical position of each marker.
r
Figure 5. Chromosome-wide plots for copy number distribution. Four representative chromosomes (1, 3, 17 and 20) are shown in this figure.
See Figure S2 for the same plots for all chromosomes. Red and blue bars at the top and bottom in each plot designate actively transcribed and high
copy number regions, respectively. Green triangles represent location of the BCAS2 (chromosome 1), PSMD6 (chromosome 3) , PPM1D (chromosome
17) and NCOA3 (chromosome 20) gene loci, respectively.
doi:10.1371/journal.pone.0001803.g005
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PLoS ONE | www.plosone.org 9 March 2008 | Volume 3 | Issue 3 | e1803Figure 6. OmicBrowse display for the BCAS2 gene. Experimental results (tiling arrays and array CGH) together with genome annotation are
represented along the genomic coordinate using OmicBrowse, a web-based genome browser. The upper panel shows the copy number (1st lane)
and BCAS2 gene locus (2nd lane) in chromosome 1. The lower panel represents a detailed view of this locus with 5 lanes. Each lane represents 1) H3K9
acetylation signals in the control experiment, 2) RNA mapping signal in the control experiment, 3) Ensembl Gene with exon-intron structure, 4)
human CAGE tag counts, and 5) a region of BCAS2 derived from the NCBI Entrez Gene database. The height of the vertical bars in the 1st and 2nd
lanes corresponds to the strength of the signals. Light green bars in the top 2 lanes represent regions with significant signal intensity. The upper
panel shows that BCAS2 is located in amplified regions. In the lower panel, a high level of acetylation around the TSS, significant and higher signal
intensity of the RNA map at exons, and a high CAGE tag can be seen for BCAS2. These data support the view that BCAS2 was expressed in the absence
of exogenous stimuli.
doi:10.1371/journal.pone.0001803.g006
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PLoS ONE | www.plosone.org 10 March 2008 | Volume 3 | Issue 3 | e1803To calculate signal intensity ratio for X chromosome, gender
information of the sample is necessary. Because called gender is
not reported in the report file for Affymetrix GeneChip Mapping
250K Nsp EA array, we did not calculate signal intensity ratio for
X chromosome in this study.
Identification of HRG-induced up- and down-regulated
genes from the H3K9 acetylation and RNA mapping data
In an effort to identify HRG-induced up-regulated genes, signal
intensities in the control experiment (without HRG treatment)
were subtracted from those obtained following HRG treatment.
Genes satisfying both Ahrg2Acontrol$a and Rhrg2Rcontrol$b were
regarded as being up-regulated. Here, Acontrol and Ahrg represent the
acetylation signal (average of 210 log (p-value) in the promoter
region) before and after HRG treatment, respectively. Similarly,
Rcontrol and Rhrg refer to the average RNA map signals in exons in
untreated cells and 2 hrs after HRG treatment, respectively. For
down-regulated genes, the left-hand member was multiplied by -1.
Thresholds a and b were set to 4 and 2, respectively. After
obtaining the list of RefSeq accession numbers, these were
converted to Entrez Gene IDs using the accession number
mapping table provided at the NCBI ftp site (ftp://ftp.ncbi.nih.
gov/gene/DATA). RefSeq entries without corresponding Entrez
Gene IDs were discarded in subsequent analyses.
Prediction of upstream TF binding site
In an effort to determine potential transcriptional regula-
tory relationships, TFBS predicted from the UCSC genome
browser database (http://hgdownload.cse.ucsc.edu/goldenPath/
hg17/database) were utilized. Since the version of the human
genome used in the tiling array and array CGH analysis was NCBI
build 35, we used a corresponding data set (hg17). The region
correspondingto the bindingsite sequence searchwasrestrictedto a
2 kb upstream region from the TSS. The genomic location of
mRNAwas downloadedfrom the UCSC genome browser database
and the first base was assigned as the TSS. The relation between the
mRNA accession numbers and Entrez Gene IDs was determined
from the mapping table provided at the NCBI ftp site (ftp://ftp.
ncbi.nih.gov/gene/DATA). TF Gene IDs were initially searched
for using UniProt accession numbers. When no information was
found, TF names were matched against gene symbols. When no
Gene ID was found, the TF was discarded from the analysis.
EnrichmentofTFBSs fora specificgene setwastestedusingFisher’s
exact test (implemented using the ‘fisher.test’ function in the R
language) followed by Bonferroni’s correction. When searching for
ER binding sites, in addition to predicted TFBSs as described
above, information from TRANSFAC [41] and pattern search imple-
mentationusing3consensussequences,TCGACGCTTTCAAGGTCA-
TATCCG,TCGACAAAGTCAGGTCACAGTGACCTGATCAAG
andGGTCANNNTGACC,where‘N’representsanarbitrarynucleotide,
[9,42]were alsoutilized.
Supporting Information
Figure S1 OmicBrowse display for the LOC400214 gene. The
OmicBrowse display comprises 8 lanes and each lane represents 1)
copy numbers in non-treated cells, 2) and 3) H3K9 acetylation
signals in the control and HRG-treated cells, respectively, 4) and 5)
RNA mapping signals in the control and HRG-treated cells,
respectively, 6) location of Ensembl Gene with exon-intron
structure, 7) human CAGE tag counts, and 8) location of the
gene obtained from NCBI Entrez Gene. The height of the vertical
bars in the 2nd, 3rd, 4th and 5th lanes reflects the strength of the
signals. Light green vertical bars in these lanes show regions with
significant signal intensity.
Found at: doi:10.1371/journal.pone.0001803.s001 (2.86 MB TIF)
Figure S2 Copy number distribution in MCF-7 cells. Red and
blue bars at the top and bottom in each plot designate actively
transcribed and high copy number regions, respectively. The
location of 7 genes (GEM, KLF10, MRPS23, MYC, NME1, PTRH2
and TRIB1) is represented by green triangles.
Found at: doi:10.1371/journal.pone.0001803.s002 (1.21 MB PDF)
Figure S3 E2-regulated TFs involved in the KEGG MAPK
signaling pathway. Twelve TFs related to estrogen-induced genes
involved in the KEGG MAPK signaling pathway are highlighted
by a blue box. TFs are color-coded according to changes in
expression of target genes (blue: down, purple: both up and down).
Note that since Elk-1 appears twice in the figure (downstream of
classical MAP kinase pathway and JNK and p38 MAP kinase
pathway), 13 boxes are highlighted.
Found at: doi:10.1371/journal.pone.0001803.s003 (2.84 MB TIF)
Table S1 HRG-induced up- and down-regulated genes identi-
fied from integrated H3K9 acetylation and RNA mapping data
Found at: doi:10.1371/journal.pone.0001803.s004 (0.07 MB XLS)
Table S2 The list of predicted transcription factors for HRG-
induced up- and down-regulated genes
Found at: doi:10.1371/journal.pone.0001803.s005 (0.02 MB
XLS)
Table S3 The list of predicted transcription factors with
relatively small p-values for HRG- and E2-induced genes.
Found at: doi:10.1371/journal.pone.0001803.s006 (0.02 MB
XLS)
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